- New China Life’s year-to-date (YTD) premium income has reached 73.22 billion yuan as of April 2025.
- This figure indicates a significant year-on-year growth of 28% in premium income.
- Analyst recommendations for New China Life show diverse opinions:
- 10 analysts have given a ‘buy’ recommendation.
- 5 analysts have issued a ‘hold’ recommendation.
- 5 analysts suggest selling the stock.
New China Life Insurance on Smartkarma
Analyst coverage of New China Life Insurance on Smartkarma reveals insightful research by Asia Real Estate Tracker on February 20, 2025. The report highlights a bearish sentiment towards the company, emphasizing APAC investor sentiments towards rate cuts and the property market in Hong Kong. Major investments in an Aussie warehouse portfolio, a housing joint venture, and data center growth are showcased as key developments influencing market dynamics. The collaboration between Vanke and government insurers for a $220M housing joint venture also underscores state support in the real estate sector.
The report by Asia Real Estate Tracker provides valuable insights for investors interested in New China Life Insurance. By analyzing market trends and investment activities, the research helps investors navigate the complexities of the insurance industry and make informed decisions. With a focus on the impact of rate cuts and property market dynamics, the report offers a comprehensive view of factors influencing New China Life Insurance‘s performance in the dynamic APAC market.
A look at New China Life Insurance Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 4 | |
| Growth | 5 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on Smartkarma Smart Scores, New China Life Insurance appears to have a positive long-term outlook. With high scores in key areas such as Value, Dividend, and Growth, the company seems well-positioned for future success. A score of 4 in Value indicates that the company offers good value to investors, while a Growth score of 5 suggests strong potential for expansion. Additionally, a Dividend score of 4 shows that the company is committed to rewarding shareholders.
However, New China Life Insurance scores lower in Resilience and Momentum, with scores of 3 in both areas. This may indicate some level of vulnerability to external factors and a slower pace of market momentum. Despite this, the company’s core focus on providing life insurance, accident insurance, and health insurance products positions it well in the insurance industry. Overall, New China Life Insurance‘s solid performance in key areas bodes well for its future stability and growth in the long term.
##### New China Life Insurance Company Limited provides life insurance in local and foreign currencies, acts as an insurance agent, provides checks, claims, and insurance consulting. The Company’s main products include life insurance, accident insurance, and health insurance products and services. #####
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars
